维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="Tilgen"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer显示文摘	Faruk Tas Ceren Tilgen Yasasever Senem Karabulut Didem Tastekin Derya Duranyildiz	2015	Biomedicine & Pharmacotherapy2015，，：	1
2	Allergic contact dermatitis of the lips in a recorder player caused by African blackwood 显示文摘	Pfshler C Hamsch C Tilgen W	2008	Contact dermatitis2008，59，3：	1
3	Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum 显示文摘	Hasselmann D O Rappl G Tilgen W at al	2001	Clin Chem2001，47，8：	1
4	Present Concepts and Future Outlook:Function of Peroxisome Proliferator-Activated Receptors (PPARs) for Pathogenesis,Progression,and Therapy of Cancer显示文摘	SERTZNIG P SEIFERT M TILGEN W	2007	Journal of Cellular Physiology2007，212，：	1
5	Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo显示文摘	Seiter S Ugurel S Tilgen W	2000	Int J Dermatol2000，39，8：	1
6	Activation of vitamin D receptor (VDR)- and peroxisome proliferator- activated receptor ( PPAR)-signaling pathways through 1, 25 (OH) ( 2 ) D ( 3 ) in melanoma cell lines and other skin- derived cell lines 显示文摘	Sertznig P Seifert M Tilgen W	2009	Dermatoendocrinol2009，1，4：	1
7	Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients显示文摘	UGUREL S RAPPL G TILGEN W	2001	Clin Cancer Res2001，7，5：	1
8	Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in hu- man serum显示文摘	Hasselmann DO Rappl G Tilgen W	2001	Clin Chem2001，47，：	1
9	Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum显示文摘	Hasselmann DO Rappl G Tilgen W		Clin Chern0，47，8：	1
10	Expression of CD44 splice variants in human skin and epidermal tumours显示文摘	Seiter S Tilgen W Herrmann K	1996	Virchows Arch1996，428，3：	1
11	Shear strength-suction relationship of compacted Ankara clay显示文摘	Cokca E Tilgen H P	2010	Applied Clay Science2010，49，：	1
12	Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer显示文摘	SERTZNIG P SEIFERT M TILGEN W	2007	J Cell Physiol2007，212，1：	1
13	Prodynorphin gene promoter polymorphism and temporal lobe epilepsy显示文摘	Tilgen N Rebstock J Horvath S	2003	Ann Neurol2003，53，2：	1
14	Extraeellular tyrosinase rnRNA within apoptotie bodies is protected from degradation in human serum显示文摘	Hasselmann DO Rappl G Tilgen W	2001	Clin Chem2001，47，8：	1
15	Pyoderma gangrenosum:clinical presentation and outcome in 18 cases and review of the literature显示文摘	Hasselmann DO Bens G Tilgen W	2007	J Dtsch Dermatol Ges2007，5，7：	1
16	Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival显示文摘	Ugurel S Rappl G Tilgen W	2001	J Clin Oncol2001，19，2：	1
17	Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival显示文摘	Ugurel S Rappl G Tilgen W	2001	J Clin Oncol2001，19，2：	1
18	Use of high-dose methvlprednislone pulse therapy in patients with progressive and stable vitiligo显示文摘	Seiter S Ugurel S Tilgen W	2000	Int J Dematol2000，39，8：	1
19	Mitofilin and titin as target antigens in melanoma-associated retinopathy显示文摘	Pfohler C Preuss K D Tilgen W	2007	Int J Cancer2007，120，4：	1
20	Experimentelle Tumortherapie beim malignen Melanom und ihre Rationale显示文摘	Dr. K. Rass M. Diefenbacher W. Tilgen	2008	Der Hautarzt2008，，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示